Codexis vs Gevo
CDXS and GEVO side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CDXS and GEVO compare
Gevo is the larger company, worth 2.4 times as much as Codexis ($309M against $130M).
Gevo grew revenue faster over the last twelve months (121% versus 35.9% for Codexis).
Codexis keeps more of each dollar of sales as profit, with a net margin of −39.6% compared with −120% at Gevo.
Gevo scores higher on the StockData Score (9 against 5 for Codexis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CDXS | GEVO |
|---|---|---|
| Size and price | ||
| Market cap | $130M | $309M |
| Share price | $1.19 | $1.25 |
| Change, 1 year | −50.8% | −45.4% |
| Change, 5 years | −97.0% | −83.0% |
| Beta (5Y) | 2.41 | 1.73 |
| Employees | 146 | 151 |
| StockData Score | ||
| Total score | 5 | 9 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 2 | 4 (better) |
| Performance score | 1 | 1 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.7× (better) | 1.7× |
| P/B | 4.0× | 1.1× (better) |
| FCF yield | −9.3% (better) | −18.3% |
| Fair value | $1.22 | $2.62 |
| Margin of safety | 2.1% | 52.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 35.9% | 121% (better) |
| Revenue growth, 5Y average | 0.38% | 96.1% (better) |
| Profitability | ||
| Gross margin | 87.0% (better) | 47.3% |
| Operating margin | −35.6% (better) | −103% |
| Net margin | −39.6% (better) | −120% |
| FCF margin | −15.7% (better) | −31.9% |
| Return on equity | −69.4% | −57.0% (better) |
| Return on invested capital | −91.8% | −29.8% (better) |
| Financial health | ||
| Debt / equity | 1.24 | 0.61 (better) |
| Interest coverage | – | −8.8× |
| Current ratio | 3.06 (better) | 2.70 |
| Altman Z-score | −6.05 | −2.77 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 63.7% | 37.2% |
| Held by insiders | 2.2% | 4.8% |
| Insider net buying, 12 months | −$7.6M | −$2.7M (better) |
| Short interest, % of float | 4.5% | 9.4% |
Go deeper
- CDXS stock overview
- CDXS income statement
- CDXS valuation and score
- GEVO stock overview
- GEVO income statement
- GEVO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.